Edgewell Personal Care (EPC) FY2024 results: revenue $2.3 billion, up 0.1% on the year

Edgewell Personal Care Co. (EPC) reported revenue of $2.3 billion for fiscal 2024, the year ended 30 September 2024, up 0.1% on the year before. Net income was $99 million, down 14.0%, and diluted earnings per share $1.97. The figures are the company's own, from the 10-K it filed with the SEC on 14 November 2024.

Revenue

$2.3 billion

+0.1% on the year

FY2017FY2024

Operating margin

8.8%

10.1% a year earlier

FY2017FY2024

Net income

$99 million

-14.0% on the year

FY2017FY2024

Diluted EPS

$1.97

-10.9% on the year

FY2017FY2024

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2024 · Q2 FY2024 · Q3 FY2024 · Q4 FY2024

Income statement (profit and loss)

$ million	FY2024	FY2023	FY2022	On the year
Revenue	2,254	2,252	2,172	+0.1%
Cost of revenue	1,298	1,311	1,292	-1.0%
Gross profit	956	941	879	+1.6%
Gross margin	42.4%	41.8%	40.5%
Research and development	58.4	58.5	55.5	-0.2%
Selling, general and administrative	430	410	n/a	+5.0%
Operating income	199	227	182	-12.2%
Operating margin	8.8%	10.1%	8.4%
Interest expense	76.5	78.5	71.4	-2.5%
Pre-tax income	121	148	124	-18.1%
Income tax	22.3	33.0	24.6	-32.4%
Effective tax rate	18.4%	22.3%	19.8%
Net income	98.6	115	99.5	-14.0%
Net margin	4.4%	5.1%	4.6%
Diluted EPS	$1.97	$2.21	$1.85	-10.9%

$ million except per share.

Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ million	FY2024	FY2023	FY2022	On the year
Operating cash flow	-231	-216	102
Capital expenditure	56.5	49.5	56.4	+14.1%
Free cash flow	-288	-266	45.6
Free cash flow margin	-12.8%	-11.8%	2.1%
Cash from investing	-62.4	-50.5	-355
Cash from financing	-179	-146	-17.6
Depreciation and amortisation	88.0	91.4	89.9	-3.7%
Share-based compensation	26.5	27.5	23.8	-3.6%
Buybacks	58.5	75.2	125	-22.2%
Dividends paid	30.7	31.5	32.6	-2.5%
Diluted shares, weighted	50m	52m	54m	-3.3%
Shares outstanding at period end	49m	50m	52m	-2.4%

Balance sheet

$ million	FY2024	FY2023	FY2022	On the year
Shareholders' equity	1,584	1,540	1,467	+2.8%
Debt	1,300	1,380	1,405	-5.8%
Operating lease liabilities	69.8	53.9	41.5	+29.5%
Other liabilities	778	766	800	+1.5%
Total liabilities and equity	3,731	3,741	3,713	-0.3%
Fixed assets	349	338	346	+3.3%
Goodwill	1,339	1,331	1,322	+0.5%
Intangible assets	948	974	997	-2.6%
Cash and equivalents	209	216	189	-3.4%
Receivables	109	106	137	+3.0%
Inventory	477	492	449	-3.1%
Other assets	299	283	274	+5.8%
Total assets	3,731	3,741	3,713	-0.3%

10-K for the year ended 30 September 2024, filed 14 November 2024: the filing.